D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Pennant Group
PNTG
$889M
| $8.28M | 0.01% |
421,830
+6,814
| +2% | +$134K |
|
902
Lemonade
LMND
$3.73B
| $8.25M | 0.01% |
502,795
+98,230
| +24% | +$1.61M |
|
903
Independent Bank
INDB
$3.5B
| $8.22M | 0.01% |
+157,993
| New | +$8.22M |
|
904
Bread Financial
BFH
$2.98B
| $8.21M | 0.01% |
220,486
-114,640
| -34% | -$4.27M |
|
905
Avanos Medical
AVNS
$576M
| $8.2M | 0.01% |
411,780
+77,663
| +23% | +$1.55M |
|
906
World Kinect Corp
WKC
$1.44B
| $8.2M | 0.01% |
309,874
+19,844
| +7% | +$525K |
|
|
SILV
907
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $8.19M | 0.01% |
1,229,270
-13,246
| -1% | -$88.2K |
|
|
ANSC
908
Agriculture & Natural Solutions Acquisition Corp
ANSC
$472M
| $8.17M | 0.01% |
+804,500
| New | +$8.17M |
|
909
Gildan
GIL
$8.23B
| $8.16M | 0.01% |
219,787
-136,890
| -38% | -$5.08M |
|
910
iShares MSCI United Kingdom ETF
EWU
$2.95B
| $8.15M | 0.01% |
+238,296
| New | +$8.15M |
|
911
Replimune Group
REPL
$469M
| $8.15M | 0.01% |
997,786
+754,780
| +311% | +$6.17M |
|
912
Skechers
SKX
$9.49B
| $8.15M | 0.01% |
133,004
-171,568
| -56% | -$10.5M |
|
913
Nabors Energy Transition Corp II
NETD
$241M
| $8.1M | 0.01% |
778,728
| – | – |
|
914
CSX Corp
CSX
$61.2B
| $8.09M | 0.01% |
218,207
+111,918
| +105% | +$4.15M |
|
915
Editas Medicine
EDIT
$244M
| $8.08M | 0.01% |
1,089,240
-98,324
| -8% | -$730K |
|
916
Coursera
COUR
$1.78B
| $8.06M | 0.01% |
574,874
-330,501
| -37% | -$4.63M |
|
917
MACOM Technology Solutions
MTSI
$9.76B
| $8.05M | 0.01% |
84,192
-105,012
| -56% | -$10M |
|
|
AAN
918
DELISTED
The Aaron's Company, Inc.
AAN
| $8.03M | 0.01% |
1,071,302
-16,906
| -2% | -$127K |
|
919
Cellebrite
CLBT
$4.2B
| $8.03M | 0.01% |
725,146
+254,038
| +54% | +$2.81M |
|
920
Aurora
AUR
$10.3B
| $8.02M | 0.01% |
2,844,422
-254,893
| -8% | -$719K |
|
921
CVS Health
CVS
$94.7B
| $7.97M | 0.01% |
99,919
-27,822
| -22% | -$2.22M |
|
|
DCPH
922
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.97M | 0.01% |
506,384
+117,721
| +30% | +$1.85M |
|
923
Bentley Systems
BSY
$16.2B
| $7.96M | 0.01% |
152,454
+136,840
| +876% | +$7.15M |
|
924
RTX Corp
RTX
$211B
| $7.94M | 0.01% |
81,393
-22,407
| -22% | -$2.19M |
|
925
Interactive Brokers
IBKR
$28.2B
| $7.93M | 0.01% |
283,820
-199,120
| -41% | -$5.56M |
|